Added to YB: 2026-09-22
Pitch date: 2026-09-20
HIMS [bullish]
Hims & Hers Health, Inc.
+2.98%
current return
Author Info
No bio for this author
Company Info
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally.
Market Cap
$6.5B
Pitch Price
$28.50
Price Target
N/A
Dividend
N/A
EV/EBITDA
801.91
P/E
-45.01
EV/Sales
2.81
Sector
Health Care Providers and Services
Category
growth
Hims & Hers: The Next Specialty Growth Driver Is Taking Shape
HIMS (update): Hims & Hers’ testosterone offering is an underappreciated growth driver: only three quarters after launch, it is already the company’s fastest-scaling specialty outside weight loss. Management expects it to become Hims’ sixth U.S. specialty to reach a $100M annual revenue run rate, with injectable and oral testosterone-replacement therapies planned before year-end.
Read full article (1 min)